Arterial Stiffness and Pharmacological Interventions – The TRanscend Arterial stiffNess Substudy (TRANS study)

References

• AsmarRArterial stiffness and pulse wave velocity – Clinical applications1999ParisElsevier943
   Google Scholar
• AsmarRSafarMEPulse wave velocity. Principles and measurementsArterial stiffness and pulse wave velocity – clinical applications1999ParisElsevier2553 Chap. III
   Google Scholar
• AsmarRSafarMEPulse wave velocity and therapyArterial stiffness and pulse wave velocity – clinical applications1999ParisElsevier14357 Chap. VII
   Google Scholar
• AsmarRBenetosATopouchianJAssessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studiesHypertension199526485907649586
   PubMed Web of Science ®Google Scholar
• AsmarRBenetosADarneBConverting enzyme inhibition: dissociation between antihypertensive and arterial effectsJ Hum Hypertens1992a638151464895
   PubMed Web of Science ®Google Scholar
• AsmarRIannascoliFBenetosADose optimisation study of arterial changes associated with angiotensin converting enzyme inhibition in hypertensionJ Hypertens1992b10Suppl 51319
   Google Scholar
• AsmarRGossePTopouchianJEffects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertensionJ Renin Angiotensin Aldosterone Syst200231768012563568
   PubMed Web of Science ®Google Scholar
• AsmarRTopouchianJPannierBon behalf of the Scientific, Quality control, Coordination and Investigation Committees of the Complior StudyPulse Wave velocity as endpoint in large-scale intervention trial. Complior® studyJ Hypertens2001198131811330885
   PubMed Web of Science ®Google Scholar
• AsmarRTargetting effective blood pressure control with angiotensin receptor blockersInt J Clin Pract2006603152016494647
   PubMed Web of Science ®Google Scholar
• BarnettAHBainSCBouterPAngiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathyN Engl J Med200435119526115516696
   PubMed Web of Science ®Google Scholar
• BlacherJGuerinAPPannierBImpact of aortic stiffness on survival in end-stage renal diseaseCirculation1999992434910318666
   PubMed Web of Science ®Google Scholar
• BoutouyriePTropeanoAIAsmarRAortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal studyHypertension200239101511799071
   PubMed Web of Science ®Google Scholar
• BrennerBMCooperMEde ZeeuwDEffects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyN Engl J Med2001345861911565518
   PubMed Web of Science ®Google Scholar
• CruickshankKRisteLAndersonSGAortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?Circulation200210620859012379578
   PubMed Web of Science ®Google Scholar
• DalhöfBDevereuxRBKjeldsenSECardiovascular Morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (life): A randomised trial against atenololLancet2002359995100311937178
   PubMed Web of Science ®Google Scholar
• DernellisJPanaretouMAortic stiffness is an independent predictor of progression to hypertension in nonhypertensive subjectsHypertension2005454263115710784
   PubMed Web of Science ®Google Scholar
• FoxKEuropean Trial On reduction of cardiac events with Perindopril in Stable Coronary Artery Disease InvestigatorsEfficacy of Perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)Lancet2003362782813678872
   PubMed Web of Science ®Google Scholar
• HollenbergNKSeverPSThe past, present and future of hypertension management : a potential role for AT1-receptor antagonistsJ Renin Angiotensin Aldosterone Syst2000151011967784
   PubMedGoogle Scholar
• HOPE/HOPE-TOO Study InvestigatorsLong-term effects of Ramipril on Cardiovascular Events and on Diabetes. Results of the HOPE Study ExtensionCirculation200511213394616129815
   PubMed Web of Science ®Google Scholar
• LacourcièreYLenisJOrchardRA comparison of the efficacy and duration of action of the angiotensin II receptor blocker telmisartan to amlodipineBlood Press Monit1998329530210212369
   PubMedGoogle Scholar
• LaurentSBoutouyriePAsmarRAortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patientsHypertension20013712364111358934
   PubMed Web of Science ®Google Scholar
• LaurentSKatsahianSFassotCAortic stiffness is an independent predictor of fatal stroke in essential hypertensionStroke2003341203612677025
   PubMed Web of Science ®Google Scholar
• LaurentSBoutouyriePSafarMEO’RourkeMFDetermination of systemic and regional arterial stiffnessHandbook of hypertension – arterial stiffness in hypertension2006ParisElsevier5362 Chap. I–4
   Google Scholar
• LaurentSKingwellBBankAClinical applications of arterial stiffness: therapeutics and pharmacologyAm J Hypertens200215453812022248
   PubMed Web of Science ®Google Scholar
• LewisEJHunsickerLGClarkeWRRenoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesN Engl J Med20013458516011565517
   PubMed Web of Science ®Google Scholar
• Mattace-RasoFUvan der CammenTJHofmanAArterial stiffness and risk of coronary heart disease and stroke: the Rotterdam StudyCirculation2006113657316461838
   PubMed Web of Science ®Google Scholar
• MeaumeSBenetosAHenryOFAortic pulse wave velocity predicts cardiovascular mortality in subjects.70 years of ageArterioscler Thromb Vasc Biol20012120465011742883
   PubMed Web of Science ®Google Scholar
• NeutelJMSmithDHGDose response and antihypertensive efficacy of the AT1 receptor antagonist telmisartan in patients with mild to moderate hypertensionAdv Ther19981520617
   Web of Science ®Google Scholar
• O’BrienEAsmarRBeilinLPractice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurementJ Hypertens20052369770115775768
   PubMed Web of Science ®Google Scholar
• ParvingHHLehnertHBrochner-MortensenJThe effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetesN Engl J Med2001345870811565519
   PubMed Web of Science ®Google Scholar
• PROGRESS Collaborative GroupRandomised trial of a perindopril-based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attackLancet200135810334111589932
   PubMed Web of Science ®Google Scholar
• RajzerMKlocekMKawecka-JaszczKEffect of Amlodipine, Quinapril, and Losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypetensionAm J Hypertens2003164394412799091
   PubMed Web of Science ®Google Scholar
• Therapeutic aspects of arterial stiffness and wave reflectionsSafarMEO’RourkeMFHandbook of hypertension – arterial stiffness in hypertension2006ParisElsevier459580 Chap. V
   Google Scholar
• ShokawaTImazuMYamamotoHPulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angeles-Hiroshima studyCirc J2005692596415731528
   PubMed Web of Science ®Google Scholar
• StrawnWBDeanRHFerrarioCMNovel mechanisms linking angiotensin II and early atherogenesisJ Renin Angiotensin Aldosterone Syst20001111711967786
   PubMedGoogle Scholar
• Sutton-TyrrellKNajjarSSBoudreauRMHealth ABC StudyElevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adultsCirculation200511133849015967850
   PubMed Web of Science ®Google Scholar
• TeoKYusufSSleightPONTARGET/TRANSCEND InvestigatorsRationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trialsAm Heart J2004148526115215792
   PubMed Web of Science ®Google Scholar
• TopouchianJAsmarRSayeghFChanges in arterial structure and function under trandolapril-verapamil combination in hypertensionStroke19993010566410229744
   PubMed Web of Science ®Google Scholar
• Van BortelLMDuprezDStarmans-KoolMJApplications of arterial stiffness, Task Force III: recommendations for user proceduresAm J Hypertens2002154455212022247
   PubMed Web of Science ®Google Scholar
• WhiteWBDuprezDSt HilaireREffects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertensionHypertension2003421021614557281
   PubMed Web of Science ®Google Scholar
• Willum-HansenTStaessenJATorp-PedersenCPrognostic value of aortic pulse wave velocity as index of arterial stiffness in the general populationCirculation20061136647016461839
   PubMed Web of Science ®Google Scholar
• YoungJBDunlapMEPfefferMAMortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trialsCirculation200411026182615492298
   PubMed Web of Science ®Google Scholar
• YusufSSleightPPogueJEffects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study InvestigatorsN Engl J Med20003421455310639539
   PubMed Web of Science ®Google Scholar